Thrivent Financial for Lutherans’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,336
Closed -$1.31M 2526
2020
Q4
$1.31M Hold
2,336
﹤0.01% 1577
2020
Q3
$1.63M Sell
2,336
-905
-28% -$706K ﹤0.01% 1269
2020
Q2
$2.56M Hold
3,241
0.01% 938
2020
Q1
$1.93M Buy
3,241
+2,588
+396% +$2.52M 0.01% 968
2019
Q4
$742K Buy
+653
New +$710K ﹤0.01% 1666

Other funds holding BLUE

Thrivent Financial for Lutherans's BLUE Position: Q1 2021 in Review

Thrivent Financial for Lutherans sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 2,336 shares — an estimated $1.31M sold.

Thrivent Financial for Lutherans first reported a position in BLUE in Q4 2019 and held it in 5 quarters. The position peaked at $2.56M in Q2 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Thrivent Financial for Lutherans reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 2,336 bluebird bio shares in Q1 2021, an estimated $1.31M.
  • Thrivent Financial for Lutherans first reported a position in bluebird bio in Q4 2019 and held it in 5 quarters.
  • Thrivent Financial for Lutherans's bluebird bio position peaked at $2.56M in Q2 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2021, filed 17 May 2021.